Independent · Evidence-based · Practical
Search peptide profiles, FDA-approved drugs, research-stage compounds, clinical updates, safety notes, and citation-backed deep dives.
Browse the A–Z index or ask the AI assistant a question.
Research integrity
Laboratory testing · Coming soon
One coded sample. Three facilities testing independently. All three reports returned to the client.
Each sample will be assigned a code before submission. The client's and source's identity will not be passed to the facilities.
Three independent facilities will each test the coded sample without reference to one another's work.
Results will return to PeptideSciences101, and the client will receive all three facility reports — not a summary or a selected result.
When reports differ, those differences will remain visible. No report will be replaced by a selected, blended, or averaged result.
Analytical testing does not establish clinical safety, effectiveness, or suitability for treatment.
Profiles are grouped by what the evidence actually shows — from FDA-approved drugs to compounds with only preclinical data. The two evidence buckets count only profiles whose grade has completed editorial review; the two regulatory buckets cover the whole catalog.
100 profiles are awaiting editorial review and carry no evidence grade yet, so they are not counted in the Human evidence or Preclinical buckets. How we grade evidence
Body Protection Compound-157 is a synthetic peptide derived from a protective protein sequence found in gastric juice. It is commonly discussed for tissue repair, but human clinical evidence remains limited.
Vladonix is a natural peptide complex derived from the thymus glands of young calves (no older than 12 months). It belongs to the "Cytomax" class of organ-specific peptide bioregulators developed at the St. Petersburg Institute of Bioregulation and Gerontology under Professor Vla
Syn-Coll is the trade name for palmitoyl tripeptide-5, a synthetic lipopeptide with the sequence palmitoyl-Lys-Val-Lys (CAS 623172-55-4; molecular weight approximately 611.9 g/mol as free base). It was developed by Pentapharm, now part of DSM-Firmenich, and functions as a growth
GHRP-4 is a synthetic tetrapeptide with the primary sequence D-Trp–L-Ala–L-Trp–D-Phe–NH2 (molecular weight 607.7 Da; molecular formula C34H37N7O4). It belongs to the growth hormone-releasing peptide (GHRP) family, a series of met-enkephalin analogs incorporating unnatural D-amino
Dihexa (systematic name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide; also designated PNB-0408) is a synthetic, metabolically stabilized small peptide derived from angiotensin IV (AngIV), the hexapeptide fragment of angiotensin II. Its Tyr-Ile dipeptide core is flanked by an N-term
8 recently updated profiles shown.
Live reference activity
A field guide connecting inherited DNA to the peptides cells make — and how that differs from making one in a lab. Nine chapters plus a reference atlas. No cost — sign in to read.
Read the guide →Clinical updates, regulatory changes, newly reviewed peptide profiles, and citation-backed research summaries. No vendor promotions.
We respect your privacy.
An arcade game over the peptide catalog: rocks split by category and regulatory status into real compounds, and every run ends on their profiles.
Play Chain Reaction →Growth hormone, muscle mass, fat loss
Delta sleep-inducing peptide
Longevity, telomere support
Wound healing, skin regeneration
GH secretagogue, anti-aging
FDA labels, DailyMed, ClinicalTrials.gov, and PubMed-indexed studies.
Clinical trials are separated from animal, in-vitro, and mechanistic evidence.
Approved drugs are clearly separated from research-stage peptides.
Unapproved compounds are not presented as treatments.
Each profile shows its evidence grade, or says plainly that editorial review is still pending.